Small molecule as potent hepatocellular carcinoma progression inhibitor through stabilizing G-quadruplex DNA to...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• G-quadruplex (G4) DNA structures are prevalent in tumor cells and represent a promising anticancer target.
• Tanshinone IIA derivatives are being investigated for their therapeutic potential.

Purpose of the Study:

• To investigate the antitumor activity of TA-1, a tanshinone IIA derivative, against liver cancer.
• To elucidate the mechanism of action of TA-1, focusing on its interaction with G4 DNA.

Main Methods:

• In vitro and in vivo studies were conducted to assess TA-1's effects on liver cancer cells.
• Analysis included G4 DNA binding and stabilization assays, DNA damage assessment, angiogenesis inhibition assays, and examination of key molecular pathways (ATM-Chk2-p53, 53BP1 expression).

Main Results:

• TA-1 effectively binds and stabilizes multiple G4 DNA structures.
• TA-1 induces replication-stress-dependent DNA damage and suppresses angiogenesis in both in vitro and in vivo models.
• TA-1 promotes 53BP1 expression, activating toxic NHEJ repair and inducing apoptosis via the ATM-Chk2-p53 pathway.
• TA-1 demonstrated significant inhibitory effects on liver cancer cell proliferation and progression.

Conclusions:

• TA-1 is a potent G-quadruplex stabilizer with significant antitumor activity against liver cancer.
• TA-1's mechanism involves G4 DNA stabilization, leading to DNA damage, suppressed angiogenesis, and apoptosis.
• TA-1 represents a promising therapeutic agent for liver cancer treatment.